[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:blood-eosinophil-count":3},{"name":4,"total":5,"recruiting":5,"trials":6},"Blood eosinophil count",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT04380038","Viral Infection in Asthma (VIA) Study",[11],"Phase 4","RECRUITING","2026-08-26T02:15:57.572488Z","2026-05-05T02:35:31.898096Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06959095","Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)",[19],"Phase 3","2026-08-26T02:19:08.862440Z","2026-05-05T02:35:31.688782Z"]